Tech Company Financing Transactions
DesignMedix Funding Round
On 7/17/2014, DesignMedix received financing from Bellingham Angels, Keiretsu Forum - Seattle and Oregon Angel Fund.
Transaction Overview
Company Name
Announced On
7/17/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The funds will help to support further development of a pipeline of drugs that combat drug resistance, including malaria drugs and new anti-bacterial drugs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2828 SW Corbett Ave. 121
Portland, OR 97201
USA
Portland, OR 97201
USA
Phone
Website
Email Address
Overview
DesignMedix, Inc. develops drugs to address the large medical need caused by the rise in drug resistance in multiple diseases like malaria and diarrhea.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sandra Shotwell
Chief Scientific Officer
David Peyton
VP - Regulatory Affairs
Katherine Liebman
Browse more venture capital transactions:
Prev: 7/17/2014: Guevara venture capital transaction
Next: 7/17/2014: ROCKI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs